Publication details
Cílená léčba nemalobuněčného karcinomu plic (NSCLC) - nutná vyšetření před rozhodnutím o volbě preparátu
| Title in English | Targeted treatment of non-small cell lung carcinoma -examinations necessary for deciding the choice of drugs |
|---|---|
| Authors | |
| Year of publication | 2016 |
| Type | Article in Periodical |
| Magazine / Source | Postgraduální medicína |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | non-small cell lung carcinoma; morphologic diagnostics; activation mutation; chemotherapy; biological treatment; immunotherapy |
| Description | Lung cancer belongs among the most common malignancies in both Europe and the world in general. In recent years, treatment of NSCLC is seeing considerable development, which leads to increased survival of patients with certain types of morphologic diagnoses or certain molecular genetic markers. With current possibilities for NSCLC treatment, it is very important to make a precise morphologic diagnosis and especially in cases of adenocarcinoma, genetic testing should be done as well. Thanks to new drugs, new options are appearing for treatment of squamous carcinomas and for treatment of 2nd line of NSCLC as well. |